Clinical Trial Update: Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on adjunctive use of flupentixol (Fute) in patients with schizophrenia treated with multi-acting receptor-targeted antipsychotics; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Psychosis
• Schizophrenia

Drugs mentioned

• Fute (flupentixol)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Schizophrenia; Psychosis, Metabolic Syndrome | Phase 4 | Status: COMPLETED